ORBIMED ADVISORS LLC

Position in KRYS — Krystal Biotech, Inc.

CIK 1055951 New York, NY

Position in KRYS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$30,922,944

+$13,073,032 QoQ

Shares Held

83,200

+20.4% QoQ

Ownership

0.281%

of shares outstanding

% of Portfolio

0.61%

of 13F equity value

Holder Rank

#44

of 419 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 51% Shared 0% None 49%

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. KRYS ranks #33 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EWTX	Edgewise Therapeutics, Inc.	15,518,492	$630,516,329
2	ELVN	Enliven Therapeutics, Inc.	6,776,632	$343,914,074
3	MBX	MBX Biosciences, Inc.	3,428,736	$189,266,227
4	GPCR	Structure Therapeutics Inc.	2,209,400	$118,578,498
5	SION	Sionna Therapeutics, Inc.	2,555,877	$112,433,029
6	CRVS	Corvus Pharmaceuticals, Inc.	7,165,006	$107,045,189
7	AVBP	ArriVent BioPharma, Inc.	3,027,328	$105,169,374
8	ARGX	Argenx SE	92,880	$86,171,277

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$30,922,944	83,200	+20.4%	Shares	Defined	2026-08-14
2026-03-31	$17,849,912	69,100	-42.3%	Shares	Defined	2026-05-15
2025-12-31	$29,535,492	119,800	+16.6%	Shares	Defined	2026-02-17
2025-09-30	$18,137,574	102,745	+1016.8%	Shares	Defined	2025-11-14
2025-06-30	$1,264,632	9,200	-60.9%	Shares	Sole	2025-08-14
2025-03-31	$4,237,050	23,500	0.0%	Shares	Sole	2025-05-15
2024-12-31	$3,681,510	23,500	0.0%	Shares	Sole	2025-02-14
2024-09-30	$4,277,705	23,500	-21.6%	Shares	Sole	2024-11-14
2024-06-30	$5,502,956	29,966	-19.4%	Shares	Sole	2024-08-14
2024-03-31	$6,612,946	37,166	-64.2%	Shares	Sole	2024-05-15
2023-12-31	$12,865,022	103,700	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.